|
| |
Thermo Fisher Scientific Unveils a New Solution to Increase Sensitivity of
In Vitro Toxicity Testing
The Thermo Scientific Cellomics ToxInsight IVT Platform
Boston, MA., (June 9, 2009) — Thermo Fisher Scientific Inc., the world
leader in serving science, today announced the launch of the Thermo Scientific
Cellomics ToxInsight Solution at the World Pharmaceutical Congress, June 9-11
2009, Philadelphia. The Thermo Scientific Cellomics ToxInsight Solution offers a
unique combination of imaging hardware and analysis software, and couples
pre-validated panels of toxicity assessment targets, to provide a robust risk
assessment tool for in vitro toxicity testing.
Traditional methods of assessing toxicity in vitro measure single targets and
have a record of low predictive power. Recent published research has shown that
cellular imaging, which combines multiple toxicity targets in single cells
provides better indicators of compound toxicity. Such rich profiles of cellular
toxicity have the potential to revolutionize the way toxicity testing is
performed, from reducing late stage drug failures due to adverse toxicity (hence
lowering overall drug development costs), to better understanding of the effect
of environmental toxins as well as ensuring the products we use from shampoos to
topical skin treatments are safe.
Harnessing the power of cell imaging to make multiple toxicity assessments on a
cell by cell basis, the ToxInsight IVT Platform, for the first time, unites
automated instrumentation, software, and reagent ‘cartridges’ within a simple,
intuitive workflow, offering improved sensitivity and specificity compared to
traditional methods. ToxInsight delivers the tools needed to drive a new
standard for in vitro toxicity testing, allowing deeper insights and better
decisions to be made earlier in the discovery process.
The ToxInsight IVT Platform, including the reader hardware, software, and
biological assessment cartridges, such as “organelle health” and
“proliferation/cell death”, can be seen at the Thermo Scientific booth #203 at
the World Pharmaceutical Congress, June 9-11 2009, Philadelphia.
For more information on the Thermo Scientific Cellomics range of products please
call 1-800-432-4091. Alternatively please visit
www.thermo.com/toxinsight.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in
serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science, enabling our customers to make the world healthier, cleaner and safer.
With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and
serve over 350,000 customers within pharmaceutical and biotech companies,
hospitals and clinical diagnostic labs, universities, research institutions and
government agencies, as well as environmental and industrial process control
settings. Serving customers through two premier brands, Thermo Scientific and
Fisher Scientific, we help solve analytical challenges from routine testing to
complex research and discovery. The Thermo Scientific brand represents a
complete range of high-end analytical instruments as well as laboratory
equipment, software, services, consumables and reagents to enable integrated
laboratory workflow solutions. Fisher Scientific provides a complete portfolio
of laboratory equipment, chemicals, supplies and services used in healthcare,
scientific research, safety and education. Together, we offer the most
convenient purchasing options to customers and continuously advance our
technologies to accelerate the pace of scientific discovery, enhance value for
customers and fuel growth for shareholders and employees alike. Visit
www.thermofisher.com
For further press information please contact: Eleanor CallanMonk, The Scott
Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United
Kingdom Tel: + 44 1477 539 539 Fax: +44 1477 539 540 E-mail:
cellular@scottpr.com
###
FOR IMMEDIATE RELEASE
Cellular
Media Contact Information:
Secondary Contact Information:
Name: Eleanor Callan
Monk Mark Collins
Phone: +44 1477 539539
+1 412 770 2200
Email: cellular@scottpr.com
mark.collins@thermofisher.com
www.thermo.com/toxinsight
| |
|
